Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.

Is liraglutide safe and effective in the elderly obese patients?: A single center experience

Open access

Abstract

The prevalence of Obesity is increasing globally, including in Türkiye, and affects all age groups, including the elderly. Previous clinical trials have shown the efficacy and safety of liraglutide in reducing the body weight of older adults. This study aimed to evaluate the effectiveness of liraglutide on weight loss and to identify any adverse effects in elderly individuals with obesity. This retrospective cohort study included patients aged ≥ 60 years with a body-mass index (BMI) ≥ 27 or greater and other comorbidities, as well as those with an initial BMI ≥ 30. All patients referred from a private tertiary clinic were prescribed liraglutide for obesity treatment. Data were collected from September 2023 to September 2024, with metabolic and anthropometric parameters recorded at the first appointment, followed by the monitoring of body weight and adverse effects during treatment. The mean age of the 32 patients was 63.78 years (± 10.50 years), with 90.6% of patients being female. Their mean weight and BMI were 94.31 ± 14.82 kg and 36.49 ± 5.34 kg/m², respectively. The body weight loss percentages were 5.96% at week 4, 10.06% at week 8, 13.85% at week 12, and 15.80% at week 24 (all P < .0001). At week 24, 100% of the patients lost more than 5% and 10% of their initial weight, respectively. Nausea was the most common adverse effect observed, with no reported instances of pancreatitis. This study corroborates the findings of previous research in this field. Evidence indicates that liraglutide is both efficacious and safe for treating obesity in the elderly population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000042155

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Weight at baseline and follow-up.
Figure 1. Weight at baseline and follow-up.CC BY-NC · PubMed Central
Figure 2. Baseline and follow-up change in body weight.
Figure 2. Baseline and follow-up change in body weight.CC BY-NC · PubMed Central
Figure 3. Baseline and follow-up body mass index.
Figure 3. Baseline and follow-up body mass index.CC BY-NC · PubMed Central
Figure 4. Body weight change from start of study.
Figure 4. Body weight change from start of study.CC BY-NC · PubMed Central
Figure 5. Percentage of patients lose at least 5% and at least 10% of baseline weight.
Figure 5. Percentage of patients lose at least 5% and at least 10% of baseline weight.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 3

Metadata

Authors
Oral, A., Küçük, C., & Kayalar, Y.
Affiliations
  • Biruni University (TR)
  • Istanbul Florence Nightingale Hospital (TR)
Corresponding author
Küçük, Celalettin
Venue
Medicine
Published
2025-04-18
Volume
104
Issue
16
Pages
e42155
ISSN
  • 0025-7974 (ISSN-L)
  • 1536-5964
OpenAlex
W4409696652
Cited by
3
References
21
Citations by year
2026: 3
FWCI
1.70
Type
journal article
Language
en
Open access
Locations
  • Medicine (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
liraglutide, obesity, elderly patients, weight loss, GLP-1 receptor agonists, adverse effects, nausea, pancreatitis, body mass index
MeSH terms
Liraglutide, Aged, Female, Humans, Hypoglycemic Agents, Male, Middle Aged, Obesity, Retrospective Studies, Weight Loss, Body Mass Index, Treatment Outcome, Anti-Obesity Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is liraglutide safe and effective in the elderly obese patients?: A single center experience. https://app.cochat.ai/papers/10.1097/md.0000000000042155
The paper
Oral, A., Küçük, C., & Kayalar, Y. (2025). Is liraglutide safe and effective in the elderly obese patients?: A single center experience. Medicine. https://doi.org/10.1097/md.0000000000042155

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.